Waters Podcast # 6 : Unraveling the Analytical Complexity of Subunit Vaccines

May 14, 2010



UPLC, QTof, HDMS, and more: A practical guide to the hottest techniques driving the future of biopharmaceutical science

As firms increasingly invest in biopharmaceutical development, there is a widespread need to educate scientists in new technologies and approaches in this rapidly evolving industry. For maximum effectiveness in drug development, the application of new techniques can save time and development costs. In this podcast series, we’ll provide you with a firm knowledge of the latest technological innovations in LC and LC/MS that have been designed to address and advance the very specific needs of the many applications areas in the biopharmaceutical laboratory.Through a variety of topics highlighting our latest scientific work, this series will help you gain a better understanding of key bio-focused LC, MS, and software advancements. Learn how these solutions have been adopted by industry leaders around the world and how easy it is to implement the tools that deliver faster, better answers relating to the character and quality of your biopharmaceuticals.

In this podcast we’ll discuss how LCMS can provide important insight into developing subunit vaccines. Tasks that can be performed more efficiently include quantifying proteins in formulation, coping with formulation products, and providing a first line of analysis for these complex biotherapeutics. Modern trends towards Protein Subunit Vaccines have advantages for manufacturing and therefore warrant a careful consideration of analytical techniques that impact on business efficiency.